In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the ...
GLP-1 drugs are quickly becoming some of the most ubiquitous in the U.S., and they have drawn interest for their potential ...
What Are GLP-1s? Glucagon-like peptide-1 receptor agonists, also known as GLP-1 drugs, are a class of medications that mimic the action of ...
Could popular anti-obesity medications have an impact on alcohol misuse? KYW medical editor Dr. Brian McDonough has more from ...
Greater weight loss was linked to greater savings, which may be directionally correct but isn’t necessarily the whole story.
The FDA put both peptides on its shortage list in 2022. Semaglutide is still on that list, while the FDA lifted its shortage ...
Results from a recent survey have prompted questions about the influence of GLP-1s on the obesity rate of U.S. adults.
By Dr. Chinta Sidharthan Breakthrough discovery of TRH neurons’ role in appetite suppression opens new doors for targeted and ...
A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be ...
Researchers discovered that moderate and heavy drinkers were the most likely to reduce their alcohol consumption while using ...
As drugs like Ozempic and Wegovy keep flying off the shelves, more and more people are taking the drug into their own hands ...